CT-2103
Jump to navigation
Jump to search
CT-2103 | |
---|---|
Term | CT-2103 |
Short definition | CT-2103 - A form of the cancer drug paclitaxel combined with a protein called polylumex that may have fewer side effects and work better than paclitaxel. It is being studied to treat breast cancer, ovarian cancer, lung cancer, and other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
CT-2103 - A form of the cancer drug paclitaxel combined with a protein called polylumex that may have fewer side effects and work better than paclitaxel. It is being studied to treat breast cancer, ovarian cancer, lung cancer, and other types of cancer. It belongs to the family of so-called mitotic inhibitors. Also known as paclitaxel polilumex, paclitaxel polyglutamate and xyotax
External links
- Medical encyclopedia article on CT-2103
- Wikipedia's article - CT-2103
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski